Welcome to Eloquest Healthcare!

About Our Company

Eloquest Healthcare Inc. is a wholly owned subsidiary of Ferndale Pharma Group, Inc. that is focused specifically on serving hospitals, their clinicians, and patients. We collaborate with our customers to deliver safer, more compassionate care.

Eloquest Healthcare’s products support strategies that prevent hospital acquired infections and provide better outcomes, higher quality and lower healthcare costs.

Our Products

Why Partner With Us?

null
null

Better Clinical Outcomes

Reduced risk of central line-associated bloodstream infections (CLABSI), post-op wound contamination, and skin injuries.
null
null

Higher Quality Support

Educational resources, knowledgeable field representatives, home office support.
null
null

Lower Cost of Care

Reduced material cost from waste and lower payment penalties from improvement in care quality.

3 Main Reasons to Choose Eloquest

Better Clinical Outcomes

We strive for better clinical outcomes. Eloquest Healthcare works towards reduced risk of central line-associated bloodstream infections (CLABSI), post-op wound contamination, and skin injuries.

Higher Quality Support

You’re not alone. Eloquest Healthcare takes pride in providing higher quality support to you and your facility. Educational resources, knowledgeable field representatives, home office support are just a few of the things we provide for you.

Lower Cost of Care

Eloquest Healthcare aims to lower your facility’s cost of care through reduced material cost from waste and lower payment penalties from improvement in care quality.

RECENT NEWS & EVENTS

august, 2019

No Events

Methicillin‐resistant Staphylococcus aureous contamination of surgical wounds: Are there effective interventions?

Methicillin‐resistant Staphylococcus aureous contamination of surgical wounds: Are there effective interventions?

Surgical Site Infections (SSIs) in the US SSIs are the most common and most costly type of hospital‐acquired infection, occurring in an estimated 160,000 to 300,000 patients in the US each year.[1] SSIs increase morbidity and mortality, result in longer hospital stays and substantially increased cost of care. In fact, it has been demonstrated that…

Read more
Blog Title: The New ReliaTect Instructional Video

CGI for HCP Product Education: The New ReliaTect Instructional Video

Instructional videos are a very important tool often used to educate healthcare providers on safe use of medical devices.  They provide a great platform to deliver detailed and easy-to-digest instructions whether the device is of a more complicated nature or not.  Video can be a great complement to printed tools, but when is the last…

Read more

Surgical Scars: Prevalence and Importance of Prevention

Each year in the US more than 50 million surgeries are performed.1 Treatment of resulting surgical scars has driven decades of research, and it is estimated that in the US $20 billion per year is spent on scar treatment and management.2 Patients have made it clear that they are highly concerned about scarring after surgery…

Read more